UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000060708 |
|---|---|
| Receipt number | R000069452 |
| Scientific Title | Effects of Long-term HAGmi Application on Skin Microbiota and Stratum Corneum Condition |
| Date of disclosure of the study information | 2026/02/19 |
| Last modified on | 2026/02/19 19:02:21 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effects of Long-term HAGmi Application on Skin Microbiota and Stratum Corneum Condition
Acronym
Effects of Long-term HAGmi Application on Skin Microbiota and Stratum Corneum Condition
Scientific Title
Effects of Long-term HAGmi Application on Skin Microbiota and Stratum Corneum Condition
Scientific Title:Acronym
Effects of Long-term HAGmi Application on Skin Microbiota and Stratum Corneum Condition
Region
| Japan |
Condition
Condition
Healthy Adults
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study aims to investigate the impact of a 4-week application of HAGmi on skin microbiota and corneal layer moisture content in male and female subjects between the ages of 18 and under 70.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Skin microbiota
Key secondary outcomes
Stratum corneum hydration, Transepidermal water loss, Evaluation of the stratum corneum (to be measured as necessary)
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Non-randomized
Randomization unit
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Other |
Interventions/Control_1
Apply either Test Product A or Test Product B to the right cheek twice daily (morning and evening) for four consecutive weeks
Interventions/Control_2
Apply either Test Product A or Test Product B to the left cheek twice daily (morning and evening) for four consecutive weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 70 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1.Persons who received a sufficient explanation of the purpose and contents of the research, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate
2.Persons who are Japanese citizens, aged 18 or older and under 70 at the time of consent
Key exclusion criteria
1.Persons who may develop skin irritation or roughness upon application of the test product (HAGmi)
2.Persons who have a chronic disease and are receiving medical treatment, or those with a history of serious illness.
3.Persons who habitually use the test product (HAGmi) (three or more days per week), or those who have done so within one month prior to the pre-study screening
4.Persons who usually take medicine, specified health food, healthy food and supplements that may have the skin condition or other supplements that are expected to have cosmetic effects
5.Persons who regularly use vitamin A (tretinoin, retinol, retinol analogues) in their skin care
6.Persons who have experience with cosmetic treatments on the face
7.Persons with obvious inflammation on the face or skin diseases diagnosed by a doctor
8.Persons who are undergoing hormone replacement therapy
9.Persons who have eyelash extensions
10.Persons who have artificial makeup on the outer corner of the eyes
11.Persons who drink a large amount of alcohol (60 g or more of alcohol per day: approximately 1500 mL of beer, 540 mL of wine, 3 cups of sake, or 180 mL of double-sized whiskey)
12.Persons who are at risk of developing allergies related to the test foods
13.Persons who are judged unsuitable as research subjects based on their responses to a background survey
14.Persons who have participated in other research during one month prior to the start of this research, or plan to participate in other research after consenting to this research.
15.Persons who are breastfeeding, pregnant, or have plans to become pregnant during the study period
16.Persons who are judged to be ineligible by the principal investigator
Target sample size
25
Research contact person
Name of lead principal investigator
| 1st name | Takumi |
| Middle name | |
| Last name | Tochio |
Organization
BIOSIS Lab. Co., Ltd.
Division name
CEO
Zip code
090 -6904-6772
Address
Room 506, Building No. 11, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, JAPAN
TEL
090-6904-6772
takumitochiobiz@gmail.com
Public contact
Name of contact person
| 1st name | Takumi |
| Middle name | |
| Last name | Tochio |
Organization
BIOSIS Lab. Co., Ltd.
Division name
CEO
Zip code
470-1101
Address
Room 506, Building No. 11, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, JAPAN
TEL
090-6904-6772
Homepage URL
takumitochiobiz@gmail.com
Sponsor or person
Institute
BIOSIS Lab. Co., Ltd.
Institute
Department
Personal name
Funding Source
Organization
Gun Ei Chemical Industry Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Ethics Committee of Healthcare Systems Co., Ltd.
Address
1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN
Tel
03-6809-2722
soumu@hc-sys.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 02 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2026 | Year | 02 | Month | 03 | Day |
Date of IRB
| 2026 | Year | 02 | Month | 19 | Day |
Anticipated trial start date
| 2026 | Year | 02 | Month | 19 | Day |
Last follow-up date
| 2026 | Year | 08 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 02 | Month | 19 | Day |
Last modified on
| 2026 | Year | 02 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069452
